P&H HC Calls for Urgent Proposals on Prison Safety Measures  ||  Delhi HC: Summons Issued to Nashville Fried Chicken' in Trademark Infringement Suit by KFC  ||  Delhi HC: Cannot Waive Timelines under Rule 100 of Trade Marks Rules, 2017  ||  Rajasthan HC Takes Suo Moto Cognizance of News Report Claiming Non-Functioning of 16 Lok Adalats  ||  Delhi HC: Mere Suspicion of an Affair does Not Meet Threshold of Section 306 of IPC  ||  SC: Delay Should Not be Condoned Merely as an Act of Generosity  ||  SC: Married Daughter Presumed to be Financially Supported by Husband  ||  SC: Cruelty u/s 498A of IPC Can’t be Established Without Specific Instances  ||  SC: Section 10 of TPA Not Applicable to Government Allotments  ||  SC: It Is Difficult to Accept that Every Form of Playing Cards Involves Moral Turpitude    

Celgene Settles Revlimid Patent Dispute with Natco Pharma - (24 Dec 2015)

Natco Pharma Ltd and partner Allergan Plc has settled dispute with US-based drug maker Celgene Corp. in the patent infringement case of the latter’s cancer drug Revlimid.

Tags : NATCO PHARMA   CELGENE CORP   REVLIMID PATENT  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved